inVentiv Health to Acquire i3 Businesses from Ingenix

In The News
January 27, 2011

Ropes & Gray represented inVentiv Health in its proposed acquisition of the clinical development businesses i3 Research, i3 Statprobe and i3 Pharma Resourcing from Ingenix, announced Jan. 20.

The proposed transaction, covering businesses that generate approximately $400 million in annual gross revenue, is expected to close in the first half of this year. 

The Ropes & Gray deal team was led by Boston-based partner Julie Jones, New York-based partner Jay Kim and Boston-based associate Taylor Hart.